Kerstin Görlich

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

Felicitas Thol, Sofia Kade, Carola Schlarmann et al. · Blood · 2012 · 418 citations · Full text

Medicine, Genetics, Molecular Genetics +11

Impact of <i>IDH1</i> R132 Mutations and an <i>IDH1</i> Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic Factor

Katharina Wagner, Frédérik Damm, Gudrun Göhring et al. · Journal of Clinical Oncology · 2010 · 240 citations

Life Sciences, Genetics, Molecular Genetics +16

Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML

Anuhar Chaturvedi, Michelle Cruz, Nidhi Jyotsana et al. · Blood · 2013 · 208 citations · Full text

Medicine, Genetics, Molecular Genetics +10

Prognostic Value of Minimal Residual Disease Quantification by Real-Time Reverse Transcriptase Polymerase Chain Reaction in Patients With Core Binding Factor Leukemias

Jürgen Krauter, Kerstin Görlich, Oliver G. Ottmann et al. · Journal of Clinical Oncology · 2003 · 127 citations

Medicine, Hematology, Oncology +15

Integrative prognostic risk score in acute myeloid leukemia with normal karyotype

Frédérik Damm, Michael Heuser, Michael Morgan et al. · Blood · 2011 · 115 citations · Full text

Medicine, Hematology, Oncology +11